Physician profile
Michael Tanious
NPI 1972009249
$4,538.56
in general payments reported to CMS, 2019-2025
6 companies · $3,367 in 2025
The $3,367 reported for 2025 was more than what 81% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $139 · 2023: $658 · 2024: $375 · 2025: $3,367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,324 · Food and Beverage: $2,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,324.39 |
| Food and Beverage | $2,074.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,547.94 | 2022-2025 | Indigo System |
| Terumo Medical Corporation | $962.31 | 2025 | Glidesheath Slender, Angio-Seal |
| Cook Medical LLC | $574.75 | 2023-2025 | Zilver Vena, Rosch-Uchida, Tornado |
| Boston Scientific Corporation | $269.58 | 2023-2024 | Obsidio, Embold Fibered, Icefx Cryoablation System |
| Bard Peripheral Vascular, INC. | $152.23 | 2023 | |
| Stryker Corporation | $31.75 | 2023 | Spinejack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tanious listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.